Sanofi to acquire Principia Biopharma
The late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases has entered into a definitive agreement with Sanofi
Breaking News
Novacyt signs contract to supply PCR instruments to UK DHSC
This is the second major contract awarded by the DHSC to Primerdesign, Novacyt’s molecular diagnostics division, ...
Sanofi completes Principia Biopharma acquisition
Principia Biopharma is now a wholly owned subsidiary of Sanofi
Thomas H. Lee Partners and Frazier Healthcare Partners acquire Adare
The transaction includes specialty CDMO business, including pharmaceutical technology and microbiome businesses
Royal Society of Chemistry calls for R&D investment
The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...
Gilead acquires Immunomedics for $21bn
The transaction is anticipated to close during Q4 2020
Scenic Biotech enters into genetic modifier collaboration with Genentech
Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...
Beximco Pharma: The Bangladeshi company connecting with the US
COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms
DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno- ...
T-knife and Catalent Sign to collaborate on autologous T-cell receptor-based cell therapy
Under the terms of the agreement, Catalent will undertake transfer of T-knife´s platform process for T-cell receptor- ...
The experiment: human versus machine
In this article Miha Možina, PhD, Business Developer at Sensum discusses why he believes investment decisions should ...
Addressing the need for cost-effective vaccine manufacturing
Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...
BioCity predicts proliferation of workspace amid life science ventures boom
The UK's life science incubator has released the Life Science Start-Up Report with in-depth analysis of emerging ...
Inflazome announces acquisition by Roche
Inflazome is a pioneering inflammasome company developing orally available NLRP3 inflammasome inhibitors to address ...
ERS Genomics signs deal with Applied StemCell
ERS Genomics holds an exclusive worldwide license from Dr Charpentier to the foundational patents covering CRISPR/Cas9
In Brief
Most Popular in Finance
- Emma Stoddart appointed CFO at ChargePoint Technology
- Royal Society of Chemistry calls for R&D investment
- GW Pharmaceuticals reports Epidiolex sales of $296 million in first year
- FTC approves GSK and Novartis deal provided Novartis sells Habitrol nicotine patch business
- Beximco Pharma introduces first generic remdesivir for COVID-19
Reports
